将翔一

502 posts

将翔一 banner
将翔一

将翔一

@makeikusaka

四十代兼業投資家。オンコリス🐿 16年から保有開始 john sedivy Transposon Therapeutics Precision Virologics Unleash Immuno Oncolytic Domain Associates Team BBV154

Katılım Aralık 2016
345 Takip Edilen112 Takipçiler
将翔一
将翔一@makeikusaka·
16かぁ
日本語
0
0
3
338
将翔一
将翔一@makeikusaka·
半年の遅れ #StudyPageTop" target="_blank" rel="nofollow noopener">classic.clinicaltrials.gov/ct2/history/NC…
日本語
0
0
5
610
将翔一
将翔一@makeikusaka·
準備中 PI for a clinical trial sponsored by the Alzheimer’s Association, and is a site clinician for clinical trials sponsored by Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.
English
0
1
7
880
将翔一
将翔一@makeikusaka·
Importantly, drugs like lecanemab and donanemab are not cures for AD and there is no evidence to suggest that these agents halt or reverse cognitive impairment. 併用か
日本語
0
0
5
581
将翔一
将翔一@makeikusaka·
Alzheimer 期待
日本語
0
0
3
361
将翔一
将翔一@makeikusaka·
Oncolys USA, Inc.. Unfortunately, at this time, we do not have any job vacancies.
English
1
0
2
368
将翔一
将翔一@makeikusaka·
Happy days are here again!
English
0
0
3
260
将翔一
将翔一@makeikusaka·
#StudyPageTop" target="_blank" rel="nofollow noopener">clinicaltrials.gov/ct2/history/NC… 7件でおわりか! オンコリ
日本語
3
0
12
2.5K
将翔一
将翔一@makeikusaka·
#StudyPageTop" target="_blank" rel="nofollow noopener">clinicaltrials.gov/ct2/history/NC…
ZXX
0
0
9
2.3K